Efficacy and safety of niraparib combined with oral etoposide in platinum-resistant/refractory ovarian cancer (PROC): a single arm, phase 2 study

Proceedings of the 7th Biennial Meeting of Asian Society of Gynecologic Oncology(2021)

Cited 0|Views3
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined